{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:55:13Z","timestamp":1777359313361,"version":"3.51.4"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":214,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,6,12]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p> <jats:italic>Helicobacter pylori<\/jats:italic> infection, gastric acid hypersecretion and NSAID consumption may cause peptic ulcer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To investigate the respective roles of <jats:italic>H. pylori<\/jats:italic> and acid secretion in bleeding duodenal ulcer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods:<\/jats:title><jats:p>A total of 99 duodenal ulcer patients were referred for evaluation of acid secretion: seven with Zollinger\u2013Ellison Syndrome; 14 with hypersecretory duodenal ulcer, defined by the coexistence of elevated basal acid output and pentagastrin acid output; and 78 duodenal ulcer patients with normal acid output. All non\u2010Zollinger\u2013Ellison Syndrome patients were <jats:italic>H. pylori<\/jats:italic>\u2010positive and cured of infection. All patients were followed\u2010up for a 36\u2010month period, to assess the occurrence of bleeding episodes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Twenty\u2010nine patients had at least one bleeding episode in the 4\u2003years before the study. Bleeding was more frequent in males and in patients on NSAIDs. The mean basal acid output was not higher among bleeders. In the 21 patients (14 hypersecretory duodenal ulcer, seven Zollinger\u2013Ellison Syndrome) with basal acid output\u2003&gt;\u200310\u2003meg\/h and pentagastrin acid output\u2003&gt;\u200344.5\u2003meg\/h, the risk of bleeding was higher (OR 6.5; 95% CI: 2\u201321). In the follow\u2010up period, three out of 83 (3.3%) non\u2010Zollinger\u2013Ellison Syndrome patients had a <jats:italic>H. pylori<\/jats:italic>\u2010negative duodenal ulcer with bleeding. The risk of bleeding after <jats:italic>H. pylori<\/jats:italic> cure was not higher in hypersecretory duodenal ulcer patients (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.3), nor among patients with previous bleeding episodes (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.2).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>In <jats:italic>H.\u2003pylori<\/jats:italic>\u2010positive duodenal ulcer patients, the coexistence of elevated basal acid output and pentagastrin acid output leads to a sixfold increase in the risk of bleeding. After <jats:italic>H. pylori<\/jats:italic> cure, gastric acid hypersecretion is not a risk factor for bleeding. However, duodenal ulcer recurrence with bleeding may occasionally occur in patients cured of <jats:italic>H. pylori<\/jats:italic>, even if acid output is normal.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.00992.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:44:49Z","timestamp":1047354289000},"page":"821-829","source":"Crossref","is-referenced-by-count":16,"title":["Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and <i>Helicobacter pylori<\/i> infection"],"prefix":"10.1111","volume":"15","author":[{"given":"G.","family":"Capurso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"D'Ambra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lahner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Delle Fave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_7_2_2","unstructured":"SollAH.Peptic ulcer and its complications. In: Sleisenger MH Fordtran JS eds. Gastrointestinal and Liver Disease 6th edn. Philadelphia: W.B. Saunders 1998: 620\u201396."},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80017-0"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007522"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098288"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000201117"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00278.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01307543"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.452_a.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.1999.99285.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.146322000.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.6.762"},{"key":"e_1_2_7_13_2","first-page":"368","article-title":"The effect of Helicobacter pylori eradication on maximal acid secretion in duodenal ulcer patients; findings and mechanisms","volume":"30","author":"Calam J","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.agast961647"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00365.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00164.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200334"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(80)90327-9"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0145-2134(96)00067-1"},{"key":"e_1_2_7_20_2","first-page":"198","article-title":"More convenient C\u2010urea breath test modifications still meet the criteria for valid diagnosis of Helicobacter pylori infection","volume":"32","author":"Braden B","year":"1994","journal-title":"Z Gastroenterol"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.4.459"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409153311107"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1996.tb01695.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70494-4"},{"key":"e_1_2_7_25_2","first-page":"225","article-title":"The conflicting relationship between Helicobacter pylori and non\u2010steroidal anti\u2010inflammatory drugs in peptic ulcer bleeding","volume":"3","author":"Bianchi Porro G","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00676.x"},{"key":"e_1_2_7_27_2","first-page":"363","article-title":"Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12\u2010month follow\u2010up study","volume":"30","author":"Louw JA","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"e_1_2_7_28_2","first-page":"195","article-title":"Helicobacter pylori modulation of gastric acid","volume":"72","author":"Calam J","year":"1999","journal-title":"Yale J Biol Med"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(00)80397-7"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3528(96)90016-0"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605023341804"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0134(199607)25:3<354::aid-prot7>3.0.co;2-f"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00992.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00992.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.00992.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:20:44Z","timestamp":1697505644000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.00992.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6,12]]}},"alternative-id":["10.1046\/j.1365-2036.2001.00992.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00992.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6,12]]}}}